BioCorRx Inc. (OTCMKTS:BICX – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.67 and traded as low as $0.30. BioCorRx shares last traded at $0.32, with a volume of 1,215 shares trading hands.
BioCorRx Stock Performance
The firm has a market capitalization of $3.15 million, a price-to-earnings ratio of -0.70 and a beta of 0.59. The firm’s 50-day moving average price is $0.41 and its two-hundred day moving average price is $0.67.
BioCorRx (OTCMKTS:BICX – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.13) EPS for the quarter.
About BioCorRx
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Recommended Stories
- Five stocks we like better than BioCorRx
- Overbought Stocks Explained: Should You Trade Them?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- 5 discounted opportunities for dividend growth investors
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
